TY - JOUR
T1 - cooperation and competition between the binding of coup-tfII and NF-Y human epsilon and gamma globin gene promoters
AU - LIBERATI, C.
AU - MR, CERA
AU - SECCO, P
AU - SANTORO, Claudio Ventura
AU - MANTOVANI, R
AU - OTTOLENGHI, S
AU - RONCHI, A.
PY - 2001
Y1 - 2001
N2 - The nuclear receptor COUP-TFII was recently shown to bind to the promoter of the ε- and γ-globin genes and was identified as the nuclear factor NF-E3. Transgenic experiments and genetic evidence from humans affected with hereditary persistence of fetal hemoglobin suggest that NF-E3 may be a represser of adult ε and γ expression. We show that, on the ε-promoter, recombinant COUP-TFII binds to two sites, the more downstream of which overlaps with an NF-Y binding CCAAT box. Binding occurs efficiently to either the 5′ or the 3′ COUP-TFII site but not to both sites simultaneously. However, adding recombinant NF-Y induces the formation of a stable COUP-TFII-NF-Y-promoter complex at concentrations of COUP-TFII that would not give significant binding in the absence of NF-Y. Mutations of the promoter indicate that COUP-TFII cooperates with NF-Y when bound to the 5′ site, whereas binding at the 3′ site is mutually exclusive. Likewise, in the γ-promoter, COUP-TFII binds to a site overlapping the distal member of a duplicated CCAAT box, competing with NF-Y binding. Transfections in K562 cells show that both the mutation of the 5′ COUP-TFII or of the NF-Y site on the ε-promoter decrease the activity of a luciferase reporter; the mutation of the 3′ COUP-TFII site has little effect. These results, together with transgenic experiments suggesting a repressive activity of COUP-TFII on the ε-promoter and the observation that, on the 3′ site, COUP-TFII and NF-Y binding is mutually exclusive, suggest that COUP-TFII may exert different effects on ε transcription depending on whether it binds to the 5′ or to the 3′ site. At the 5′ site, COUP-TFII might cooperate with NF-Y, forming a stable complex, and stimulate transcription; at the 3′ site, COUP-TFII might compete for binding with NF-Y and, directly or indirectly, decrease gene activity.
AB - The nuclear receptor COUP-TFII was recently shown to bind to the promoter of the ε- and γ-globin genes and was identified as the nuclear factor NF-E3. Transgenic experiments and genetic evidence from humans affected with hereditary persistence of fetal hemoglobin suggest that NF-E3 may be a represser of adult ε and γ expression. We show that, on the ε-promoter, recombinant COUP-TFII binds to two sites, the more downstream of which overlaps with an NF-Y binding CCAAT box. Binding occurs efficiently to either the 5′ or the 3′ COUP-TFII site but not to both sites simultaneously. However, adding recombinant NF-Y induces the formation of a stable COUP-TFII-NF-Y-promoter complex at concentrations of COUP-TFII that would not give significant binding in the absence of NF-Y. Mutations of the promoter indicate that COUP-TFII cooperates with NF-Y when bound to the 5′ site, whereas binding at the 3′ site is mutually exclusive. Likewise, in the γ-promoter, COUP-TFII binds to a site overlapping the distal member of a duplicated CCAAT box, competing with NF-Y binding. Transfections in K562 cells show that both the mutation of the 5′ COUP-TFII or of the NF-Y site on the ε-promoter decrease the activity of a luciferase reporter; the mutation of the 3′ COUP-TFII site has little effect. These results, together with transgenic experiments suggesting a repressive activity of COUP-TFII on the ε-promoter and the observation that, on the 3′ site, COUP-TFII and NF-Y binding is mutually exclusive, suggest that COUP-TFII may exert different effects on ε transcription depending on whether it binds to the 5′ or to the 3′ site. At the 5′ site, COUP-TFII might cooperate with NF-Y, forming a stable complex, and stimulate transcription; at the 3′ site, COUP-TFII might compete for binding with NF-Y and, directly or indirectly, decrease gene activity.
UR - https://iris.uniupo.it/handle/11579/9194
U2 - 10.1074/jbc.M102987200
DO - 10.1074/jbc.M102987200
M3 - Article
SN - 0021-9258
VL - 276
SP - 41700
EP - 41709
JO - THE JOURNAL OF BIOLOGICAL CHEMISTRY
JF - THE JOURNAL OF BIOLOGICAL CHEMISTRY
ER -